Status:
COMPLETED
A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
University of Dundee
National Institute for Health Research, United Kingdom
Conditions:
Transient Hypothyroxinemia
Eligibility:
All Genders
1-42 years
Phase:
PHASE4
Brief Summary
The purpose of this trial is to determine whether iodide supplementation of neonates born under 31 weeks gestation improves neurodevelopment measured at two years of age.
Detailed Description
Iodine is essential for the synthesis of thyroxine, and thyroxine is essential for normal brain development in utero and for the first 2-3 years of life. The recommended iodine intake in parenteral nu...
Eligibility Criteria
Inclusion
- All infants born under 31 weeks gestation
Exclusion
- Mother exposed to excess iodine during pregnancy or delivery
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
1275 Patients enrolled
Trial Details
Trial ID
NCT00638092
Start Date
March 1 2010
End Date
May 1 2015
Last Update
May 18 2015
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Ninewells Hospital and Medical School
Dundee, Tayside, United Kingdom, DD1 9SY
2
Royal Maternity Hospital
Belfast, United Kingdom, BT12 6BB
3
Heartlands Hospital
Birmingham, United Kingdom, B9 5SS
4
University Hospital Coventry
Coventry, United Kingdom, CV2 2DX